Focused Alpha LLC’s Merck MRK Stock Holding History

Focused Alpha LLC’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$772K	Sell	6,009 -160	-3%	-$18.7K	0.2%	102
2026 Q1	$742K	Buy	6,169 +1,598	+35%	+$184K	0.23%	93
2025 Q4	$481K	Buy	+4,571	New	+$429K	0.14%	150

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SSP

Sixth Street Partners Dallas, Texas $751B AUM 15.65% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Focused Alpha LLC's MRK Position: Q2 2026 in Review

Focused Alpha LLC reduced its Merck (MRK) stake by 2.6% in Q2 2026, selling an estimated $18.7K and leaving 6,009 shares worth $772K. The position accounts for 0.2% of the portfolio, ranked #102.

Focused Alpha LLC first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,459 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Focused Alpha LLC held 6,009 shares of Merck worth $772K as of Q2 2026.
Focused Alpha LLC sold 160 Merck shares in Q2 2026, an estimated $18.7K.
Merck made up 0.2% of Focused Alpha LLC's portfolio in Q2 2026, its #102 holding.
Focused Alpha LLC first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
3,459 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Focused Alpha LLC's 13F filing for Q2 2026, filed 7 Aug 2026.